Literature DB >> 12590354

Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.

Yossef Itzhak1, Syed F Ali, Cindy N Achat, Karen L Anderson.   

Abstract

RATIONALE: Although many studies have focused on the mechanisms underlying MDMA-induced neurotoxicity, little is known about the subsequent long-term response to psychostimulants following exposure to a neurotoxic dose of MDMA.
OBJECTIVES: We investigated the effect of pre-exposure to neurotoxic and non-neurotoxic doses of MDMA on the response of mice to the psychomotor stimulating effects of MDMA and cocaine.
METHODS: To investigate MDMA-induced neurotoxicity, male Swiss Webster mice were subjected to three regimens of MDMA: i) 40 mg/kg x 2, ii) 30 mg/kg x 2, and iii) 15 mg/kg x 2 for 2 days. On day 5 following the last exposure to MDMA, the levels of dopaminergic and serotonergic markers were determined. For the behavioral experiments, mice received either a single injection of 10 mg/kg MDMA [MDMA(L)] or one of the following doses of MDMA: 30 mg/kg x 2 or 15 mg/kg x 2 for 2 days [MDMA (H)]. A third group received saline as a control. On day 5 after the last pretreatment injection, the first MDMA (10 mg/kg) challenge was given, and on day 12, cocaine (20 mg/kg) was administered. Subsequently, mice were re-challenged with MDMA on days 35, 50 and 80, after which locomotor activity was monitored by infrared beam-interrupts. On day 83, mice were killed to detect the levels of dopaminergic and serotonergic markers.
RESULTS: MDMA-induced mortality and depletion of dopaminergic and serotonergic markers were dose-dependent. MDMA (H) mice endured a sensitized response to MDMA challenge from days 5 through 80, e.g. a persistent 3-fold increase in locomotor activity compared to the response of mice that were not pretreated with a neurotoxic dose of MDMA. The depletion of DAT and 5-HTT binding sites was sustained throughout this time period (64-68% of control). The MDMA (L) mice showed a sensitized response to MDMA only on day 5. Both MDMA (L) and MDMA (H) mice were sensitized to the cocaine challenge.
CONCLUSIONS: The induction of sensitization to the locomotor stimulating effects of MDMA and cocaine was independent of MDMA-induced neurotoxicity. However, the long-lasting maintenance of the sensitized response to MDMA may be related to the enduring neurotoxicity caused by MDMA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590354     DOI: 10.1007/s00213-002-1320-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

Authors:  B J Logan; R Laverty; W D Sanderson; Y B Yee
Journal:  Eur J Pharmacol       Date:  1988-08-02       Impact factor: 4.432

2.  Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine.

Authors:  P Nencini; W L Woolverton; L S Seiden
Journal:  Brain Res       Date:  1988-08-02       Impact factor: 3.252

3.  In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.

Authors:  U Scheffel; Z Szabo; W B Mathews; P A Finley; R F Dannals; H T Ravert; K Szabo; J Yuan; G A Ricaurte
Journal:  Synapse       Date:  1998-06       Impact factor: 2.562

4.  Effect of the dopaminergic neurotoxin MPTP on cocaine-induced locomotor sensitization.

Authors:  Y Itzhak; J L Martin; M D Black; S F Ali
Journal:  Pharmacol Biochem Behav       Date:  1999-05       Impact factor: 3.533

5.  Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase.

Authors:  Y Itzhak
Journal:  J Pharmacol Exp Ther       Date:  1997-08       Impact factor: 4.030

6.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

7.  Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.

Authors:  D L Commins; G Vosmer; R M Virus; W L Woolverton; C R Schuster; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1987-04       Impact factor: 4.030

8.  The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.

Authors:  G M Farfel; G L Vosmer; L S Seiden
Journal:  Brain Res       Date:  1992-11-06       Impact factor: 3.252

9.  Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.

Authors:  J T Winslow; T R Insel
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

10.  Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.

Authors:  C J Schmidt
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

View more
  14 in total

1.  Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats.

Authors:  Ryan A Gregg; Christopher S Tallarida; Allen B Reitz; Scott M Rawls
Journal:  Behav Pharmacol       Date:  2013-12       Impact factor: 2.293

2.  A reliable model of intravenous MDMA self-administration in naïve mice.

Authors:  José Manuel Trigo; Fany Panayi; Guadalupe Soria; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2005-12-15       Impact factor: 4.530

3.  Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.

Authors:  Daniel W Curry; Matthew B Young; Andrew N Tran; Georges E Daoud; Leonard L Howell
Journal:  Neuropharmacology       Date:  2017-10-06       Impact factor: 5.250

4.  Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization.

Authors:  Michael D Berquist; Sebastian Leth-Petersen; Jesper Langgaard Kristensen; William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2019-11-15       Impact factor: 4.530

Review 5.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

6.  Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice.

Authors:  María Juliana Orejarena; Fernando Berrendero; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2009-06-04       Impact factor: 4.530

7.  DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).

Authors:  F Fornai; P Lenzi; G Frenzilli; M Gesi; M Ferrucci; G Lazzeri; F Biagioni; M Nigro; A Falleni; M Giusiani; A Pellegrini; F Blandini; S Ruggieri; A Paparelli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-13       Impact factor: 4.530

Review 8.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

9.  Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice.

Authors:  Ainhoa Plaza-Zabala; Xavier Viñals; Rafael Maldonado; Patricia Robledo
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

10.  Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.

Authors:  Pier Francesca Porceddu; Ismail Ogunbayode Ishola; Liliana Contu; Micaela Morelli
Journal:  Neurotox Res       Date:  2016-06-01       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.